Novel PLEC-EML4-ALK Double Fusion Underlying Crizotinib Resistance in a Metastatic Inflammatory Myofibroblastic Tumor: A Case Report
ALK fusions are frequent oncogenic drivers in inflammatory myofibroblastic tumors. Treatment with crizotinib is effective in fusion-positive patients; however, acquired resistance remains a challenge. Here, we present a case of EML4-ALK-positive metastatic inflammatory myofibroblastic tumor that ini...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2025-05-01
|
| Serier: | JTO Clinical and Research Reports |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2666364325000074 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
